Wells Fargo’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Wells Fargo’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-15,000	Closed	-$218K	–	7331
2020 Q2	$218K	Hold	15,000	–	–	﹤0.01%	4861
2020 Q1	$385K	Sell	15,000 -1,700	-10%	-$21.2K	﹤0.01%	4233
2019 Q4	$188K	Buy	16,700 +2,200	+15%	+$60.7K	﹤0.01%	4992
2019 Q3	$127K	Hold	14,500	–	–	﹤0.01%	5213
2019 Q2	$137K	Hold	14,500	–	–	﹤0.01%	5166
2019 Q1	$87K	Buy	+14,500	New	+$418K	﹤0.01%	5178

Wells Fargo's PTLA Position: Q3 2020 in Review

Wells Fargo sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 78,771 shares — an estimated $1.42M sold.

Wells Fargo first reported a position in PTLA in Q2 2013 and held it in 29 quarters. The position peaked at $33.4M in Q4 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Wells Fargo reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Wells Fargo sold 78,771 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1.42M.
Wells Fargo first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 29 quarters.
Wells Fargo's Portola Pharmaceuticals, Inc. position peaked at $33.4M in Q4 2017.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Wells Fargo's 13F filing for Q3 2020, filed 5 Nov 2020.